Protocol optimization of the quantificaion of gait using the GAITRIte in children with mitochondrial disease

Protocol optimization of the quantificaion of gait using the GAITRIte in children with mitochondrial disease - GAITRite in children with mitochondrial disease

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43067

Enrollment

218

Registered

2016-09-12

Start date

2016-10-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

energy metabolism abnormalities

Interventions

Children

Gait

Mitochondrial disease

Outcome measure

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: Patients: - aged 1-18 years - genetically confirmed mitochondrial disease - able to walk 3x10 meters; five times;Healthy controls Aged 1-18 years able to walk no neurological, orthopedic or neuromuscular disease influencing gait

Exclusion criteria

Exclusion criteria: - Ernstige gedragsproblemen

Design outcomes

Primary

Measure	Time frame
Parameters of gait	—

Secondary

Measure	Time frame
3 minute walking distance	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)